IRX3 and obesity due to melanocortin 4 receptor deficiency: IRX3 plays an important role in obesity and type 2 diabetes; however, it plays an important role in the adaptability of tumor cells to metabolic challenges, a process that has a parallelism with the development of chemotherapeutic resistance (Singh et al., 2016).